https://medicine.ouhsc.edu/academic-departments Parent Page: Academic Departments id: 36009 Active Page: Motolani Adedipe (nee Ogunsanya) DPh, MS, PhDid:36011

Publications - Motolani E. Adedipe, DPh, MS, PhD

Select Publications

  1. Ogunsanya ME, Saintibert J, Bolajoko OO, Hooks D, Clifton S, Odedina FT. Mapping Behavioral Research in Post-Treatment Cancer Care in Sub-Saharan Africa: A Scoping Review. Psychooncology. 2025;34(3):e70106.
  2. Ogunsanya ME, Kaninjing E, DeForge SM, et al. Bridging the Gap: Enhancing Prostate Cancer Survivorship and Advocacy Among Ethnically Diverse Black Men Through Community Town Halls. J Cancer Educ. 2025.
  3. Kendzor DE, Davie M, Chen M, et al. Incentivizing Tobacco Helpline Engagement in Persistent Poverty Counties: A Randomized Trial. Am J Prev Med. 2025;68(2):336-347.
  4. Gustafson KA, Rowe C, Gavaza P, et al. Pharmacists' perceptions of artificial intelligence: A national survey. Journal of the American Pharmacists Association. 2025;65(1):102306.
  5. Gustafson KA, Berman S, Gavaza P, et al. Pharmacy faculty and students perceptions of artificial intelligence: A National Survey. Curr Pharm Teach Learn. 2025;17(6):102344.
  6. Sifat MS, Kenney S, Bekteshi V, et al. The association of migration-related stress with poor mental health among recently resettled Afghan refugees. J Migr Health. 2024;10:100282.
  7. Sifat MS, Ehlke SJ, Ogunsanya M, et al. Greater Discrimination Frequency and Lower Distress Tolerance Are Associated with Mental Health Problems Among Racially Privileged and Minoritized Adults Accessing an Urban Day Shelter. J Racial Ethn Health Disparities. 2024;11(1):45-61.
  8. Ogunsanya ME, Wagner JL, Bennett K, Medina MS, Starnes S, Planas LG. Debate as an Active Learning Pedagogy Among Pharmacy Students in a Public Health Course. Am J Pharm Educ. 2024;88(7):100724.
  9. Ogunsanya ME, Kaninjing E, Morton DJ, Dwyer K, Young ME, Odedina FT. Bridging the Gap: A Community Advisory Board Promoting Community Engagement in Cancer Research for Ethnically Diverse Populations. Am J Mens Health. 2024;18(5):15579883241280826.
  10. Ogunsanya ME, Kaninjing E, Ellis TN, et al. Health-related quality of life in ethnically diverse Black prostate cancer survivors: a convergent parallel mixed-methods approach. Quality of Life Research. 2024;33(10):2705-2719.
  11. Ogunsanya ME, Kaninjing E, Ellis TN, et al. Quality of life assessment among ethnically diverse Black prostate cancer survivors: a constructivist grounded theory approach. J Cancer Surviv. 2024.
  12. Ogunsanya ME, Frank-Pearce SG, Chen S, et al. The influence of sociodemographic, tobacco use, and mental health characteristics on treatment adherence among adults enrolled in a community-based tobacco cessation program. Addict Behav Rep. 2024;20:100568.
  13. Ogunsanya M, Kaninjing E, Ellis T, et al. Quality of Life Assessment Among Ethnically Diverse Black Prostate Cancer Survivors: A Constructivist Grounded Theory Approach. Res Sq. 2024.
  14. Neil J, Mao BJ, Shao RS, et al. A pilot randomized clinical trial of a smartphone-based application to support at-home PSA screening and culturally tailored prostate cancer education for African American men: A study protocol. Contemporary Clinical Trials. 2024;147.
  15. Campbell JE, Ogunsanya ME, Holmes N, VanWagoner T, James J. Bibliometric and social network analysis of a Clinical and Translational Resource awardee: An Oklahoma experience 2014-2021. J Clin Transl Sci. 2024;8(1):e10.
  16. Anyanwu P, Olateju OA, Tata V, et al. Understanding the financial barriers to treatment among individuals with opioid use disorder: a focus group study. Harm Reduct J. 2024;21(1):220.
  17. Abraham O, Agoke A, Sanuth K, et al. Need for Culturally Competent and Responsive Cancer Education for African Immigrant Families and Youth Living in the United States. JMIR Cancer. 2024;10:e53956.
  18. Ogunsanya ME, Sifat M, Bamidele OO, et al. Mobile health (mHealth) interventions in prostate cancer survivorship: a scoping review. J Cancer Surviv. 2023;17(3):557-568.
  19. Adams M, Hynan L, Ogunsanya M, Chong B. Item Reduction and Validation of the Cutaneous Lupus Erythematosus Quality of Life Questionnaire. Arthritis & Rheumatology. 2023;75:1657-1660.
  20. Walker AM, Lu G, Clifton SC, Ogunsanya ME, Chong BF. Influence of Socio-Demographic Factors in Patients With Cutaneous Lupus Erythematosus. Front Med (Lausanne). 2022;9:916134.
  21. Ezenwankwo EF, Ogbodo VE, Alom GO, et al. Behavioural oncology research in Africa: Lessons from the last two decades and key considerations moving forward. Eur J Cancer Care (Engl). 2022;31(3):e13545.
  22. Ezenwankwo EF, Nnate DA, Oladoyinbo CA, et al. Strengthening Capacity for Prostate Cancer Early Diagnosis in West Africa Amidst the COVID-19 Pandemic: A Realist Approach to Rethinking and Operationalizing the World Health Organization 2017 Guide to Cancer Early Diagnosis. Ann Glob Health. 2022;88(1):29.
  23. Bamidele OO, Alexis O, Ogunsanya M, Greenley S, Worsley A, Mitchell ED. Barriers and facilitators to accessing and utilising post-treatment psychosocial support by Black men treated for prostate cancer-a systematic review and qualitative synthesis. Support Care Cancer. 2022;30(5):3665-3690.
  24. Swaby J, Kaninjing E, Ogunsanya M. African American participation in cancer clinical trials. Ecancermedicalscience. 2021;15:1307.
  25. Ogunsanya ME, Goetzinger EA, Owopetu OF, Chandler PD, O'Connor LE. Predictors of Palliative Care Knowledge: Findings from the Health Information National Trends Survey. Cancer Epidemiol Biomarkers Prev. 2021;30(7):1433-1439.
  26. Prasad S, Raman J, Ogunsanya ME, Chong BF. Principal components analysis as a tool to identify lesional skin patterns in cutaneous lupus erythematosus. J Am Acad Dermatol. 2020;83(3):922-924.
  27. Ogunsanya ME, Cho SK, Hudson A, Chong BF. Factors associated with quality of life in cutaneous lupus erythematosus using the Revised Wilson and Cleary Model. Lupus. 2020;29(13):1691-1703.
  28. Arriens C, Aberle T, Carthen F, et al. Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers. Lupus Sci Med. 2020;7(1):e000360.